ClinicalTrials.govpublic full text
Her2-positive Lung Cancer Treated With Dedicated Drug
non small cell lung cancer metastatic, non small cell lung cancer stage iii, her2 gene mutation, ifct, nsclc, her2, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 832240
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.